Comparison of midregional pro‐atrial natriuretic peptide with N‐terminal pro‐B‐type natriuretic 
 peptide in the diagnosis of heart failure

M. Potocki,T. Breidthardt,T. Reichlin,S. Hartwiger,N. Morgenthaler,A. Bergmann,M. Noveanu,H. Freidank,A. Taegtmeyer,K. Wetzel,T. Boldanova,C. Stelzig,R. Bingisser,M. Christ,C. Mueller
DOI: https://doi.org/10.1111/j.1365-2796.2009.02135.x
2010-01-01
Journal of Internal Medicine
Abstract:Objectives.  The concentration of atrial natriuretic peptide (ANP) in the circulation is approximately 10‐ to 50‐ fold higher than B‐type natriuretic peptide (BNP). We sought to compare the accuracy of midregional pro‐atrial natriuretic peptide (MRproANP) measured with a novel sandwich immunoassay with N‐terminal pro‐B‐type natriuretic peptide (NTproBNP) in the diagnosis of heart failure.
What problem does this paper attempt to address?